Sulphonamides: N-ethylperfluorooctane sulphonamide

In 2024, sulphonamides: n-ethylperfluorooctane sulphonamide trade exhibited strong growth, with global flows reaching $487,417 and a three-year compound annual growth rate of +91.1% (five-year: -5.5%). The all-time peak of $8,237,774 was recorded in 2013; the current level is 94% below that high-water mark.

Over the 30-year observation window (1995–2024), 52% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is strengthening (+93.6% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.614). The three largest exporters — Barbados ($3.3M), United States ($858.6K), and Cuba ($508.9K) — collectively dominate supply flows. The leading exporter has grown at +86.7% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.617). The three largest import markets are Hong Kong ($448.6K), New Zealand ($369.0K), and France ($285.5K). The largest importing market sources from 2 different supplying countries.

The dominant trade corridor is Barbados → Japan at $3.2M, representing 100.0% of the importer's total demand.

The volatility score for sulphonamides: n-ethylperfluorooctane sulphonamide is 32 out of 100, classified as low. Trade flows are moderately variable, typical for goods with seasonal or cyclical demand patterns.

For market entrants, strong demand tailwinds create a favourable entry environment. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "Medium" based on reporting coverage and consistency across OECD member and partner countries.